Schedule 13G ownership disclosure

JOUNCE THERAPEUTICS INC

Security class unavailable · CUSIP: 481116101

Event date: 2022-04-21

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,080,352
Percent of class
5.9600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001085146-22-001517
Form type
SC 13G
Filer
Cowen Financial Products LLC
CIK
CIK 1771015
Filed
Apr 22, 2022
Reporting period
Apr 21, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub